Verona Pharma is a biopharmaceutical company developing and commercializing respiratory therapies, including its inhaled treatment for chronic obstructive pulmonary disease (COPD).
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 30 | New buy | 285,185 | $30,432,091 | 0.4% |
| Stanley Druckenmiller / Duquesne | 81 | Holds (flat) | 1,002,080 | $106,932 | 2.6% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.